Spero Therapeutics, Inc.·4

Dec 2, 6:05 PM ET

JOSEPH TAMARA L 4

4 · Spero Therapeutics, Inc. · Filed Dec 2, 2020

Insider Transaction Report

Form 4
Period: 2020-12-02
JOSEPH TAMARA L
Chief Legal Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-12-02+75,00075,000 total
    Exercise: $17.28Exp: 2030-12-02Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest as to 25% on December 2, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION